ROLE OF THE ROBOTIC PROCESS AUTOMATION (RPA) IN THE FINANCIAL MONITORING
Scientific bulletin · 2026-04 · 1 (16) · 149-154
DOI: 10.54414/lrwq2251 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific bulletin, 2026-04. Verfasst von Zohr Isa BABAZADE.
Abstract (Originalsprache)
This article explores the role of Robotic Process Automation (RPA) in the financial monitoring system and provides insights on increasing efficiency amidst evolving regulatory requirements and financial crimes. The prevalence of high false positive rates in manual, human-led processes underscores the critical necessity of intelligent automation. Consequently, the parallel integration of RPA alongside artificial intelligence and machine learning models is of significant importance for closing performance gaps. Research indicates that the global RPA market is projected to grow from $3.6 billion in 2025 to $20.79 billion by 2032. According to statistics and industrial experience, RPA reduces manual tasks by 95% while lowering operating costs by 25–50%. In the financial monitoring segment, this leads to the processing of suspicious activities 3.2 times faster than traditional methods. Furthermore, as financial monitoring is a highly sensitive field, the study recommends that processes must achieve an accuracy rate of approximately 99% before being transitioned to bots to avoid systemic errors. Keywords: RPA, Financial Monitoring, AML/CFT, Intelligent Automation, Compliance.
Zitieren
APA
BABAZADE, Z. I. (2026). ROLE OF THE ROBOTIC PROCESS AUTOMATION (RPA) IN THE FINANCIAL MONITORING. Scientific bulletin, 1(16), 149-154. https://doi.org/10.54414/lrwq2251
Vancouver
BABAZADE ZI. ROLE OF THE ROBOTIC PROCESS AUTOMATION (RPA) IN THE FINANCIAL MONITORING. Scientific bulletin. 2026;1(16):149-154. doi:10.54414/lrwq2251
BibTeX
@article{BABAZADE2026,
author = {BABAZADE, Zohr Isa},
title = {ROLE OF THE ROBOTIC PROCESS AUTOMATION (RPA) IN THE FINANCIAL MONITORING},
journal = {Scientific bulletin},
year = {2026},
volume = {1},
number = {16},
pages = {149--154},
doi = {10.54414/lrwq2251}
}
EUVIMED